Literature DB >> 11927915

Dyslipidemia due to retroviral protease inhibitors.

Anthony D Kelleher, Andrew K Sewell, David A Price.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11927915     DOI： 10.1038/nm0402-308a

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  3 in total

1.  Modeling metabolic effects of the HIV protease inhibitor ritonavir in vitro.

Authors:  Jeffrey Laurence; Rozbeh Modarresi
Journal:  Am J Pathol       Date:  2007-09-14       Impact factor: 4.307

2.  The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signaling.

Authors:  Michael W-H Wang; Shi Wei; Roberta Faccio; Sunao Takeshita; Pablo Tebas; William G Powderly; Steven L Teitelbaum; F Patrick Ross
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

3.  Reducing plasma HIV RNA improves muscle amino acid metabolism.

Authors:  Kevin E Yarasheski; Samuel R Smith; William G Powderly
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-09-14       Impact factor: 4.310
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.